| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.44B | 70.70B | 69.49B | 63.12B | 61.47B | 54.14B |
| Gross Profit | 28.31B | 30.65B | 27.67B | 23.64B | 25.09B | 22.77B |
| EBITDA | 11.38B | 14.41B | 15.69B | 14.75B | 12.67B | 11.40B |
| Net Income | 8.51B | 8.46B | 8.81B | 7.85B | 7.08B | 6.88B |
Balance Sheet | ||||||
| Total Assets | 128.60B | 144.72B | 135.83B | 131.05B | 119.04B | 113.81B |
| Cash, Cash Equivalents and Short-Term Investments | 39.26B | 47.43B | 48.41B | 47.45B | 39.68B | 38.76B |
| Total Debt | 21.43B | 24.36B | 30.56B | 22.23B | 20.16B | 15.66B |
| Total Liabilities | 41.90B | 50.11B | 51.66B | 44.17B | 37.23B | 32.90B |
| Stockholders Equity | 85.87B | 93.80B | 83.38B | 86.16B | 81.32B | 80.05B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.80B | 5.02B | 7.93B | -126.00M | 917.00M |
| Operating Cash Flow | 0.00 | 10.98B | 9.02B | 12.95B | 2.92B | 5.09B |
| Investing Cash Flow | 0.00 | 2.22B | -15.55B | -3.56B | -3.67B | -5.09B |
| Financing Cash Flow | 0.00 | -11.54B | -3.72B | -2.81B | 1.42B | -1.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥172.79B | 10.40 | ― | 3.50% | 3.85% | -1.53% | |
74 Outperform | ¥164.89B | 14.73 | ― | 2.84% | 6.06% | 19.76% | |
74 Outperform | ¥303.43B | 9.05 | 5.47% | 3.41% | 2.60% | 9.50% | |
74 Outperform | ¥161.04B | 8.76 | 6.23% | 1.11% | 2.88% | 16.60% | |
68 Neutral | ¥208.13B | 14.21 | ― | 1.81% | -0.52% | 5.18% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥155.53B | 9.97 | 4.24% | 3.76% | -7.81% | 25.04% |